Alexander, J.H.

ck-mb patient elevation mortality 6- month mortality level infarction ratio category trial peak ck-mb level month ck-mb elevation peak ck-mb ratios study heart creatine outcome intervention ck-mb levels syndrome peak ck-mb category peak ck-mb ratio model peak creatine kinase circulation relationship peak ck-mb levels necrosis event percutaneou 6 months periprocedural nste acs pursuit surgery result kinase heart failure admission prognostic ck-mb elevations analysis cardiol coll cardiol association limit table treatment angina infarct size 30 days 30- prognostic significance artery admission infarction enzyme califf rm 30- day baseline st-segment prognostic implications predictor .001 <0.001 30- day mortality enrolment increase infarct peak ck-mb categories significance failure death postadmission sample st-segment elevation regression model characteristic randomized glycoprotein